Novavax recruiting youngsters for vaccine trial

Novavax, a Gaithersburg-based biotechnology company currently working on a COVID-19 vaccine candidate, announced Monday that it is recruiting adolescents ages 12-17 to participate in a pediatric expansion of its ongoing phase 3 clinical trial for the vaccine in the United States. Up to 3,000 adolescents at up to 75 sites across the country will participate in the trial, with ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *